Company / Gross Margin
LivaNova Gross Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
67.7%
FY2025
5-year range
63.7% / 68.1%
FY2021-FY2025
Trend
-0.6%
vs FY2024
Sector context
#26 of 96
Health Care
What the data says
At 67.7%, LivaNova's gross margin ranks #26 of 96 in the Health Care sector. Gross Margin has fluctuated over the past 10 years, ranging from 14.6% in FY2017 to 68.1% in FY2024.
Based on SEC 10-K filings.
67.7% in FY2025 with a 5-year CAGR of +4.0%.
Improved from 65.5% to 67.7% over the past 2 years.
Health Care sector context is included.
Gross Margin over time
Growth rates
- 3-Year Change
- +4.0pp
- 5-Year Change
- +4.0pp
- 10-Year Change
- -
Sector benchmark
#26 of 96 in Health CareTop 27% of 96This company 67.7% Sector average 53.6%
▼
+26.4% above sector average
Key checks
Key Insights
- In FY2025, gross margin decreased 0.6% year-over-year.
- Currently 14.1pp above the Health Care sector average.
- Peak gross margin was recorded in FY2024.
- Lowest gross margin in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.84 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 67.7% | -0.6% |
| FY2024 | 68.1% | +3.9% |
| FY2023 | 65.5% | +2.9% |
| FY2022 | 63.7% | -4.6% |
| FY2021 | 66.8% | +4.9% |
| FY2020 | 63.7% | -4.6% |
| FY2019 | 66.8% | +356.0% |
| FY2018 | 14.6% | +0.4% |
| FY2017 | 14.6% | -74.9% |
| FY2016 | 58.0% | -15.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026